Yubo International Biotech Ltd (YBGJ)
0.845
0.00 (0.00%)
USD |
OTCM |
May 31, 16:00
Yubo International Biotech SG&A Expense (Quarterly): 0.2802M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 0.2802M |
December 31, 2023 | 0.3626M |
September 30, 2023 | 0.2759M |
June 30, 2023 | 0.2014M |
March 31, 2023 | 0.2756M |
December 31, 2022 | -0.2045M |
September 30, 2022 | 0.321M |
June 30, 2022 | 0.4488M |
March 31, 2022 | 0.4813M |
Date | Value |
---|---|
December 31, 2021 | 0.3229M |
September 30, 2021 | 0.3475M |
June 30, 2021 | 0.3737M |
March 31, 2021 | 0.4489M |
December 31, 2020 | 0.7392M |
September 30, 2020 | 0.2167M |
June 30, 2020 | 0.1541M |
March 31, 2020 | 0.0954M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
-0.2045M
Minimum
Dec 2022
0.7392M
Maximum
Dec 2020
0.3024M
Average
0.321M
Median
Sep 2022
SG&A Expense (Quarterly) Benchmarks
Meihua International Medical Technologies Co Ltd | -- |
Hologic Inc | 244.60M |
Nuwellis Inc | 4.606M |
Varex Imaging Corp | 35.50M |
Quanterix Corp | 26.92M |